PSP Society of Canada Announces first ASK THE RESEARCHER SESSION
Organization to host two Scientists & Researchers remotely to address questions from patients and caregivers
Kingston, ON – Wednesday June 2nd, 2021 – Today, The PSP Society of Canada announced that they will be facilitating their first ASK THE RESEARCHER SESSION. Alex Klein; former Vice President of Scientific Affairs for CurePSP and now Investor Relations Lead with UCB Pharmaceuticals and Colin Ewin; Early Research Lead at UCB Pharmaceuticals will be joining us.
“Alex is a long-time friend of the PSP Society of Canada” said PSP
Society of Canada Vice President Stéphane Hetherington. “He and Colin will be offering us valuable insight into the world of clinical trials and
scientific research in the neurodegeneration space.”
The objective of our ASK THE RESEARCHER SESSION is to offer our stakeholders a clear and detailed understanding of how brain research is currently being done, how complex clinical trials are conducted and what important contributions are being made by patients.
As usual, the session is open to patients, caregivers and others affected by Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA) & Corticobasal Degeneration (CBD).
The PSP Society asks that interested participants register for the free session and SUBMIT THEIR QUESTIONS IN ADVANCE via a short survey available here and through the link in the group details below. Question submissions will be taken through Friday June 11th.
The PSP Society of Canada serves patients and families dealing with Progressive Supranuclear Palsy (PSP) and related diseases such as Multiple System Atrophy (MSA) and Corticobasal Degeneration (CBD). For more information please visit. www.pspsocietycanada.ca